TITLE

Successful treatment of HIV associated cerebral vasculopathy with HAART

AUTHOR(S)
N J Cutfield
PUB. DATE
August 2009
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Aug2009, Vol. 80 Issue 8, p936
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43423706

 

Related Articles

  • Schwere Leukenzephalopathie. Ringelstein, A.; Oelschlaeger, C.; Arendt, G.; Mathys, C.; Dziewas, R.; Niederstadt, T.; Reichelt, D.; Hasselblatt, M.; Husstedt, I.W.; Saleh, A. // Nervenarzt;Dec2009, Vol. 80 Issue 12, p1496 

    Background: We hypothesize that CNS immune reconstitution inflammatory syndrome (IRIS) after highly active antiretroviral therapy (HAART) in HIV-1-positive patients may become manifest without any opportunistic infection as an aseptic leucoencephalopathy. This opens a window of opportunity for...

  • A guide to drug therapy in HIV. Turtle, Lance; Thakkar, Raj // GP: General Practitioner;6/29/2007, p26 

    The article offers information on how general practitioners can use highly active antiretroviral therapy (HAART) for the treatment of HIV. HAART aims to reduce the morbidity and mortality associated with progressive HIV disease. A list of antiretroviral drugs that can be used for HIV treatment...

  • Winning The Battle Against HIV-1. Secasan, Iosif; Pop, Dan I.; Secasan, Ciprian C. // Internet Journal of Infectious Diseases;2007, Vol. 6 Issue 1, p4 

    Objective: To present an entirely new theory and practical solution to completely eliminate HIV-1 from the human body, based on a combination between a HAART regimen (HAART-x) and a corresponding, pre-administrated-to-(HAART-x), therapeutic vaccine (Vaccine-x) made of short HIV-1 DNA-sequences...

  • Winning The Battle Against HIV-1. Secasan, Iosif; Pop, Dan I.; Secasan, Ciprian C. // Internet Journal of Infectious Diseases;2007, Vol. 6 Issue 1, p13 

    Objective: To present an entirely new theory and practical solution to completely eliminate HIV-1 from the human body, based on a combination between a HAART regimen (HAART-x) and a corresponding, pre-administrated-to-(HAART-x), therapeutic vaccine (Vaccine-x) made of short HIV-1 DNA-sequences...

  • HIV update: New strategies for a changing epidemic. Kirchner, Jeffrey T.; Raffanti, Stephen P. // Patient Care for the Nurse Practitioner;Feb2004, Vol. 7 Issue 2, p5 

    The article focuses on meeting the challenges of HIV-positive patients who present with an array of risks associated with long-term treatment. A list of anti-HIV agents is provided in this article. The success of highly active antiretroviral therapy (HAART) has largely transformed HIV infection...

  • Postinfectious vasculopathy with evolution to moyamoya syndrome. Czartoski, T.; Hallam, D.; Lacy, J. M.; Chun, M. R.; Becker, K. // Journal of Neurology, Neurosurgery & Psychiatry;Feb2005, Vol. 76 Issue 2, p256 

    Background: Parainfectious vascular events are a known complication of bacterial meningitis, typically occurring within two weeks of disease onset. Delayed vascular complications are rare. We present a case of progressive vasculopathy following bacterial meningitis.Case...

  • Better quality of life with neuropsychological improvement on HAART. Parsons, Thomas D.; Braaten, Alyssa J.; Hall, Colin D.; Robertson, Kevin R. // Health & Quality of Life Outcomes;2006, Vol. 4, p11 

    Background: Successful highly active antiretroviral therapy (HAART) regimens have resulted in substantial improvements in the systemic health of HIV infected persons and increased survival times. Despite increased systemic health, the prevalence of minor HIV-associated cognitive impairment...

  • Renal Diseases in HIV Infection. Asudani, Deepak; Patel, Ruchita S.; Corser, John // Internet Journal of Internal Medicine;2004, Vol. 5 Issue 1, p1 

    The article presents information on renal diseases in HIV infection. Even before HIV was established as the causative agent of AIDS, a distinct renal syndrome was reported in patients with AIDS and nephrotic syndrome. Renal involvement by HIV is now understood to be a direct infection by the...

  • Interleukin 2 treatment for HIV infection. Blankson, Joel; Siliciano, Robert F.; Blankson, J; Siliciano, R F // JAMA: Journal of the American Medical Association;7/12/2000, Vol. 284 Issue 2, p236 

    Editorial. Discusses the disadvantages associated with the use of highly active antiretroviral therapy (HAART) for the treatment of HIV. Challenges to the patient; Complexity and toxicity of the regimen; Rationale for the use of interleukin-2 in HIV-1 infection; Mention of two articles in this...

  • Cerebral mass lesions in patients with AIDS.  // BMJ: British Medical Journal (International Edition);7/28/90, Vol. 301 Issue 6745, p226 

    Examines the role of cerebral biopsy on patients with AIDS and cerebral mass lesions. Symptoms of the disease; Analysis on the management of the symptoms of the disease; Association between cerebral mass lesions and HIV infection treatment and cerebral biopsy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics